Per Garberg
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 8
- Drug Transport and Resistance Mechanisms 8
-
- Peroxisome Proliferator-Activated Receptors 3
- Co-authors
- Johan Högberg (8 shared papers)Bo Lundgren (4 shared papers)Brita Sjöström (2 shared papers)Folke Sjöqvist (1 shared paper)Greger Lindberg (1 shared paper)Jan Taipalensuu (1 shared paper)Hans Törnblom (1 shared paper)Håkan Melhus (1 shared paper)
In The Last Decade
Per Garberg
25 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 117
- Pharmacology 203
- Oncology 553
- Toxicology 68
- Neurology 146
- Pharmaceutical Science 80
Countries citing papers authored by Per Garberg
This map shows the geographic impact of Per Garberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Garberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Garberg more than expected).
Fields of papers citing papers by Per Garberg
This network shows the impact of papers produced by Per Garberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Garberg. The network helps show where Per Garberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Per Garberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 370 | |
| 2 | 2004 | 327 | |
| 3 | Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development. | 2007 | 245 |
| 4 | 1988 | 60 | |
| 5 | 1999 | 54 | |
| 6 | 2006 | 53 | |
| 7 | 1988 | 46 | |
| 8 | 1988 | 46 | |
| 9 | 2004 | 44 | |
| 10 | 2004 | 30 | |
| 11 | 2004 | 29 | |
| 12 | 1999 | 22 | |
| 13 | 2005 | 17 | |
| 14 | 1992 | 17 | |
| 15 | 1992 | 13 | |
| 16 | 1991 | 10 | |
| 17 | 1996 | 10 | |
| 18 | 1987 | 9 | |
| 19 | 1969 | 9 | |
| 20 | 1992 | 7 |
About Per Garberg
Per Garberg is a scholar working on Oncology, Molecular Biology, Nutrition and Dietetics, Clinical Biochemistry and Spectroscopy, having authored 25 papers that have together received 1.4k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (8 papers), Selenium in Biological Systems (6 papers), Metabolism and Genetic Disorders (4 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Analytical Chemistry and Chromatography (3 papers), Hormonal and reproductive studies (2 papers), Barrier Structure and Function Studies (2 papers) and Computational Drug Discovery Methods (2 papers). The work is most often cited by research in Pharmacology (203 citations), Oncology (553 citations), Toxicology (68 citations), Neurology (146 citations) and Pharmaceutical Science (80 citations). Per Garberg has collaborated with scholars based in Sweden, Norway and Denmark. Frequent co-authors include Johan Högberg, Bo Lundgren, Brita Sjöström, Folke Sjöqvist, Greger Lindberg, Jan Taipalensuu, Hans Törnblom, Håkan Melhus, Curt Einarsson and Per Artursson. Their work appears in journals such as Chemico-Biological Interactions, Biochemical Pharmacology, Carcinogenesis, The International Journal of Biochemistry & Cell Biology and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.